With a focus on expanding its retail presence, Vestiage, which creates and distributes nutraceuticals under such brands as RegiMEN for men and Monterey Bay Nutraceuticals for women, has appointed Laura Stall as national VP sales.
GlaxoSmithKline on Wednesday announced that the Food and Drug Administration approved Incruse Ellipta (umeclidinium), which is used for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, or COPD, including chronic bronchitis and/or emphysema.
GlaxoSmithKline and Theravance on Monday announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), a once-daily that combines two long-acting bronchodilators in a single inhaler, is now available in retail pharmacies in the United States.
U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.
GlaxoSmithKline and Genmab A/S announced last week that the Food and Drug Administration has approved a supplemental biologic license application for the use of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia for whom fludarabine-based therapy is considered inappropriate.
Rite Aid on Tuesday announced it has acquired Boston-based Health Dialog Services Corp., a provider of health coaching, shared decision making and healthcare analytics from Bupa, a London-based international healthcare services group.
Concurrent opioid prescribing by multiple providers is common in Medicare patients and is associated with higher rates of hospital admission related to opioid use, according to a study published last week in BMJ.
The National Association of Chain Drug Stores Retail Advisory Board will be heading to London on Feb. 25 to examine key marketplace trends, including multigenerational retailing, how the omni-channel is improving the shopping experience, urban retailing and managing OTC medications.
The market for electronic health and medical records is set to experience rapid growth over the coming years, with EMR peer group value estimated to climb from approximately $10.6 billion in 2012 to $17 billion by 2017, at a compound annual growth rate of 9.8%, according to research and consulting firm GlobalData.
The imminent entry of several companies — including big pharma, small biotech and generic participants — into the global biosimilars space will propel the market toward exponential growth. The market is expected to soar from $1.2 billion in 2013 to $24 billion in 2019, reported Frost & Sullivan in research released earlier this week.
Enchanted Life — a new, personal care e-commerce site where consumers can buy products, share beauty tips and learn about trends — is looking to meet the personal care needs of the multicultural community.